ID   PIGA_HUMAN              Reviewed;         484 AA.
AC   P37287; B4E0V2; Q16025; Q16250;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=Phosphatidylinositol N-acetylglucosaminyltransferase subunit A;
DE            EC=2.4.1.198;
DE   AltName: Full=GlcNAc-PI synthesis protein;
DE   AltName: Full=Phosphatidylinositol-glycan biosynthesis class A protein;
DE            Short=PIG-A;
GN   Name=PIGA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7680492; DOI=10.1126/science.7680492;
RA   Miyata T., Takeda J., Iida Y., Yamada N., Inoue N., Takahashi M.,
RA   Maeda K., Kitani T., Kinoshita T.;
RT   "The cloning of PIG-A, a component in the early step of GPI-anchor
RT   biosynthesis.";
RL   Science 259:1318-1320(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=8081362; DOI=10.1093/hmg/3.5.751;
RA   Bessler M., Hillmen P., Longo L., Luzzatto L., Mason P.J.;
RT   "Genomic organization of the X-linked gene (PIG-A) that is mutated in
RT   paroxysmal nocturnal haemoglobinuria and of a related autosomal
RT   pseudogene mapped to 12q21.";
RL   Hum. Mol. Genet. 3:751-757(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=8193350;
RA   Iida Y., Takeda J., Miyata T., Inoue N., Nishimura J., Kitani T.,
RA   Maeda K., Kinoshita T.;
RT   "Characterization of genomic PIG-A gene: a gene for
RT   glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal
RT   nocturnal hemoglobinuria.";
RL   Blood 83:3126-3131(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=8081230;
RA   Yu J., Nagarajan S., Ueda E., Knez J.J., Petersen R.B., Medof M.E.;
RT   "Characterization of alternatively spliced PIG-A transcripts in normal
RT   and paroxysmal nocturnal hemoglobinuria cells.";
RL   Braz. J. Med. Biol. Res. 27:195-201(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 301-420, AND INVOLVEMENT IN PNH1.
RX   PubMed=8500164; DOI=10.1016/0092-8674(93)90250-T;
RA   Takeda J., Miyata T., Kawagoe K., Iida Y., Endo Y., Fujita T.,
RA   Takahashi M., Kitani T., Kinoshita T.;
RT   "Deficiency of the GPI anchor caused by a somatic mutation of the PIG-
RT   A gene in paroxysmal nocturnal hemoglobinuria.";
RL   Cell 73:703-711(1993).
RN   [9]
RP   INTERACTION WITH PIGY.
RX   PubMed=16162815; DOI=10.1091/mbc.E05-08-0743;
RA   Murakami Y., Siripanyaphinyo U., Hong Y., Tashima Y., Maeda Y.,
RA   Kinoshita T.;
RT   "The initial enzyme for glycosylphosphatidylinositol biosynthesis
RT   requires PIG-Y, a seventh component.";
RL   Mol. Biol. Cell 16:5236-5246(2005).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   INVOLVEMENT IN MCAHS2.
RX   PubMed=22305531; DOI=10.1016/j.ajhg.2011.11.031;
RA   Johnston J.J., Gropman A.L., Sapp J.C., Teer J.K., Martin J.M.,
RA   Liu C.F., Yuan X., Ye Z., Cheng L., Brodsky R.A., Biesecker L.G.;
RT   "The phenotype of a germline mutation in PIGA: the gene somatically
RT   mutated in paroxysmal nocturnal hemoglobinuria.";
RL   Am. J. Hum. Genet. 90:295-300(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-24, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   VARIANT PNH1 PHE-155.
RX   PubMed=8306954;
RA   Bessler M., Mason P.J., Hilmen P., Miyata T., Yamada N., Takeda J.,
RA   Luzzato L., Kinoshita T.;
RT   "Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic
RT   mutations in the PIG-A gene.";
RL   EMBO J. 13:110-117(1994).
RN   [14]
RP   VARIANT PNH1 ASP-297.
RX   PubMed=8167330;
RA   Ware R.E., Rosse W.F., Howard T.A.;
RT   "Mutations within the Piga gene in patients with paroxysmal nocturnal
RT   hemoglobinuria.";
RL   Blood 83:2418-2422(1994).
RN   [15]
RP   VARIANTS PNH1 TRP-19; HIS-40; ALA-48; ASP-48; ARG-128 AND ARG-239.
RX   PubMed=10087994; DOI=10.1006/bcmd.1998.0203;
RA   Nafa K., Bessler M., Castro-Malaspina H., Jhanwar S., Luzzatto L.;
RT   "The spectrum of somatic mutations in the PIG-A gene in paroxysmal
RT   nocturnal hemoglobinuria includes large deletions and small
RT   duplications.";
RL   Blood Cells Mol. Dis. 24:370-384(1998).
RN   [16]
RP   VARIANT PNH1 VAL-48.
RX   PubMed=12037021; DOI=10.1136/jcp.55.6.410;
RA   Yoon J.H., Cho H.I., Park S.S., Chang Y.H., Kim B.K.;
RT   "Mutation analysis of the PIG-A gene in Korean patients with
RT   paroxysmal nocturnal haemoglobinuria.";
RL   J. Clin. Pathol. 55:410-413(2002).
RN   [17]
RP   VARIANT MCAHS2 LEU-344 DEL.
RX   PubMed=24259288; DOI=10.1002/ajmg.a.36189;
RA   Swoboda K.J., Margraf R.L., Carey J.C., Zhou H., Newcomb T.M.,
RA   Coonrod E., Durtschi J., Mallempati K., Kumanovics A., Katz B.E.,
RA   Voelkerding K.V., Opitz J.M.;
RT   "A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a
RT   neurodegenerative X-linked epileptic encephalopathy with systemic
RT   iron-overload.";
RL   Am. J. Med. Genet. A 164A:17-28(2014).
RN   [18]
RP   VARIANT MCAHS2 LEU-93.
RX   PubMed=24259184; DOI=10.1002/ajmg.a.36184;
RA   van der Crabben S.N., Harakalova M., Brilstra E.H.,
RA   van Berkestijn F.M., Hofstede F.C., van Vught A.J., Cuppen E.,
RA   Kloosterman W., Ploos van Amstel H.K., van Haaften G.,
RA   van Haelst M.M.;
RT   "Expanding the spectrum of phenotypes associated with germline PIGA
RT   mutations: a child with developmental delay, accelerated linear
RT   growth, facial dysmorphisms, elevated alkaline phosphatase, and
RT   progressive CNS abnormalities.";
RL   Am. J. Med. Genet. A 164A:29-35(2014).
RN   [19]
RP   VARIANTS MCAHS2 LEU-77; TRP-119 AND PHE-206.
RX   PubMed=24706016; DOI=10.1212/WNL.0000000000000389;
RA   Kato M., Saitsu H., Murakami Y., Kikuchi K., Watanabe S., Iai M.,
RA   Miya K., Matsuura R., Takayama R., Ohba C., Nakashima M.,
RA   Tsurusaki Y., Miyake N., Hamano S., Osaka H., Hayasaka K.,
RA   Kinoshita T., Matsumoto N.;
RT   "PIGA mutations cause early-onset epileptic encephalopathies and
RT   distinctive features.";
RL   Neurology 82:1587-1596(2014).
RN   [20]
RP   VARIANT VAL-135.
RX   PubMed=27864847; DOI=10.1002/humu.23149;
RG   Clinical Study Group;
RA   Parrini E., Marini C., Mei D., Galuppi A., Cellini E., Pucatti D.,
RA   Chiti L., Rutigliano D., Bianchini C., Virdo S., De Vita D.,
RA   Bigoni S., Barba C., Mari F., Montomoli M., Pisano T., Rosati A.,
RA   Guerrini R.;
RT   "Diagnostic targeted resequencing in 349 patients with drug-resistant
RT   pediatric epilepsies identifies causative mutations in 30 different
RT   genes.";
RL   Hum. Mutat. 38:216-225(2017).
CC   -!- FUNCTION: Necessary for the synthesis of N-acetylglucosaminyl-
CC       phosphatidylinositol, the very early intermediate in GPI-anchor
CC       biosynthesis.
CC   -!- CATALYTIC ACTIVITY: UDP-N-acetyl-D-glucosamine + 1-phosphatidyl-
CC       1D-myo-inositol = UDP + 6-(N-acetyl-alpha-D-glucosaminyl)-1-
CC       phosphatidyl-1D-myo-inositol.
CC   -!- PATHWAY: Glycolipid biosynthesis; glycosylphosphatidylinositol-
CC       anchor biosynthesis.
CC   -!- SUBUNIT: Associates with PIGC, PIGH, PIGP, PIGQ and DPM2. The
CC       latter is not essential for activity. Interacts directly with
CC       PIGY. {ECO:0000269|PubMed:16162815}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P37287-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P37287-2; Sequence=VSP_001802;
CC       Name=3;
CC         IsoId=P37287-3; Sequence=VSP_043366, VSP_043367;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Paroxysmal nocturnal hemoglobinuria 1 (PNH1)
CC       [MIM:300818]: A disorder characterized by hemolytic anemia with
CC       hemoglobinuria, thromboses in large vessels, and a deficiency in
CC       hematopoiesis. Red blood cell breakdown with release of hemoglobin
CC       into the urine is manifested most prominently by dark-colored
CC       urine in the morning. {ECO:0000269|PubMed:10087994,
CC       ECO:0000269|PubMed:12037021, ECO:0000269|PubMed:8167330,
CC       ECO:0000269|PubMed:8306954, ECO:0000269|PubMed:8500164}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Multiple congenital anomalies-hypotonia-seizures syndrome
CC       2 (MCAHS2) [MIM:300868]: An X-linked recessive developmental
CC       disorder characterized by dysmorphic features, neonatal hypotonia,
CC       myoclonic seizures, and variable congenital anomalies involving
CC       the central nervous, cardiac, and urinary systems. Most affected
CC       individuals die in infancy. {ECO:0000269|PubMed:22305531,
CC       ECO:0000269|PubMed:24259184, ECO:0000269|PubMed:24259288,
CC       ECO:0000269|PubMed:24706016}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase group 1 family.
CC       Glycosyltransferase 4 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase;
CC       Note=Phosphatidylinositol N-acetylglucosaminyltransferase subunit
CC       A;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_555";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D11466; BAA02019.1; -; mRNA.
DR   EMBL; X77725; CAB57276.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X77726; CAB57276.1; JOINED; Genomic_DNA.
DR   EMBL; X77727; CAB57276.1; JOINED; Genomic_DNA.
DR   EMBL; X77728; CAB57276.1; JOINED; Genomic_DNA.
DR   EMBL; D28791; BAA05966.1; -; Genomic_DNA.
DR   EMBL; S74936; AAD14160.1; -; mRNA.
DR   EMBL; AK303538; BAG64564.1; -; mRNA.
DR   EMBL; AC095351; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC038236; AAH38236.1; -; mRNA.
DR   EMBL; S61523; AAD13929.1; -; mRNA.
DR   CCDS; CCDS14165.1; -. [P37287-1]
DR   CCDS; CCDS48086.2; -. [P37287-3]
DR   PIR; A46217; A46217.
DR   RefSeq; NP_002632.1; NM_002641.3. [P37287-1]
DR   RefSeq; NP_065206.3; NM_020473.3. [P37287-3]
DR   RefSeq; XP_016885070.1; XM_017029581.1. [P37287-1]
DR   UniGene; Hs.137154; -.
DR   ProteinModelPortal; P37287; -.
DR   BioGrid; 111295; 26.
DR   STRING; 9606.ENSP00000369820; -.
DR   CAZy; GT4; Glycosyltransferase Family 4.
DR   iPTMnet; P37287; -.
DR   PhosphoSitePlus; P37287; -.
DR   BioMuta; PIGA; -.
DR   DMDM; 585696; -.
DR   EPD; P37287; -.
DR   MaxQB; P37287; -.
DR   PaxDb; P37287; -.
DR   PeptideAtlas; P37287; -.
DR   PRIDE; P37287; -.
DR   DNASU; 5277; -.
DR   Ensembl; ENST00000333590; ENSP00000369820; ENSG00000165195. [P37287-1]
DR   Ensembl; ENST00000482148; ENSP00000489528; ENSG00000165195. [P37287-2]
DR   Ensembl; ENST00000542278; ENSP00000442653; ENSG00000165195. [P37287-1]
DR   Ensembl; ENST00000634582; ENSP00000489540; ENSG00000165195. [P37287-3]
DR   GeneID; 5277; -.
DR   KEGG; hsa:5277; -.
DR   UCSC; uc004cwr.4; human. [P37287-1]
DR   CTD; 5277; -.
DR   DisGeNET; 5277; -.
DR   GeneCards; PIGA; -.
DR   HGNC; HGNC:8957; PIGA.
DR   HPA; HPA001174; -.
DR   MalaCards; PIGA; -.
DR   MIM; 300818; phenotype.
DR   MIM; 300868; phenotype.
DR   MIM; 311770; gene.
DR   neXtProt; NX_P37287; -.
DR   OpenTargets; ENSG00000165195; -.
DR   Orphanet; 397922; Ferro-cerebro-cutaneous syndrome.
DR   Orphanet; 300496; Multiple congenital anomalies-hypotonia-seizures syndrome type 2.
DR   Orphanet; 447; Paroxysmal nocturnal hemoglobinuria.
DR   Orphanet; 3451; West syndrome.
DR   PharmGKB; PA33288; -.
DR   eggNOG; KOG1111; Eukaryota.
DR   eggNOG; COG0438; LUCA.
DR   GeneTree; ENSGT00390000014405; -.
DR   HOGENOM; HOG000203293; -.
DR   HOVERGEN; HBG008198; -.
DR   InParanoid; P37287; -.
DR   KO; K03857; -.
DR   OMA; REKYQLH; -.
DR   OrthoDB; EOG091G060D; -.
DR   PhylomeDB; P37287; -.
DR   TreeFam; TF105675; -.
DR   Reactome; R-HSA-162710; Synthesis of glycosylphosphatidylinositol (GPI).
DR   UniPathway; UPA00196; -.
DR   GeneWiki; PIGA; -.
DR   GenomeRNAi; 5277; -.
DR   PRO; PR:P37287; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000165195; -.
DR   CleanEx; HS_PIGA; -.
DR   ExpressionAtlas; P37287; baseline and differential.
DR   Genevisible; P37287; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:HGNC.
DR   GO; GO:0000506; C:glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; IDA:HGNC.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0017176; F:phosphatidylinositol N-acetylglucosaminyltransferase activity; TAS:HGNC.
DR   GO; GO:0008194; F:UDP-glycosyltransferase activity; TAS:Reactome.
DR   GO; GO:0006506; P:GPI anchor biosynthetic process; TAS:HGNC.
DR   GO; GO:0009893; P:positive regulation of metabolic process; TAS:HGNC.
DR   GO; GO:0016254; P:preassembly of GPI anchor in ER membrane; TAS:Reactome.
DR   InterPro; IPR001296; Glyco_trans_1.
DR   InterPro; IPR013234; PIGA_GPI_anchor_biosynthesis.
DR   Pfam; PF00534; Glycos_transf_1; 1.
DR   Pfam; PF08288; PIGA; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Epilepsy; Glycoprotein; Glycosyltransferase;
KW   GPI-anchor biosynthesis; Membrane; Phosphoprotein; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    484       Phosphatidylinositol N-
FT                                acetylglucosaminyltransferase subunit A.
FT                                /FTId=PRO_0000080326.
FT   TOPO_DOM      1    421       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    422    442       Helical. {ECO:0000255}.
FT   TOPO_DOM    443    484       Lumenal. {ECO:0000305}.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    467    467       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   VAR_SEQ       1      4       MACR -> MELT (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043366.
FT   VAR_SEQ       5    238       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043367.
FT   VAR_SEQ     115    283       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8081230}.
FT                                /FTId=VSP_001802.
FT   VARIANT      19     19       R -> W (in PNH1; dbSNP:rs34422225).
FT                                {ECO:0000269|PubMed:10087994}.
FT                                /FTId=VAR_015442.
FT   VARIANT      40     40       D -> H (in PNH1).
FT                                {ECO:0000269|PubMed:10087994}.
FT                                /FTId=VAR_015436.
FT   VARIANT      48     48       G -> A (in PNH1).
FT                                {ECO:0000269|PubMed:10087994}.
FT                                /FTId=VAR_015437.
FT   VARIANT      48     48       G -> D (in PNH1).
FT                                {ECO:0000269|PubMed:10087994}.
FT                                /FTId=VAR_015438.
FT   VARIANT      48     48       G -> V (in PNH1).
FT                                {ECO:0000269|PubMed:12037021}.
FT                                /FTId=VAR_015439.
FT   VARIANT      77     77       R -> L (in MCAHS2; dbSNP:rs587777398).
FT                                {ECO:0000269|PubMed:24706016}.
FT                                /FTId=VAR_071069.
FT   VARIANT      93     93       P -> L (in MCAHS2; dbSNP:rs587777400).
FT                                {ECO:0000269|PubMed:24259184}.
FT                                /FTId=VAR_071070.
FT   VARIANT     119    119       R -> W (in MCAHS2; dbSNP:rs587777396).
FT                                {ECO:0000269|PubMed:24706016}.
FT                                /FTId=VAR_071071.
FT   VARIANT     128    128       H -> R (in PNH1).
FT                                {ECO:0000269|PubMed:10087994}.
FT                                /FTId=VAR_015440.
FT   VARIANT     135    135       A -> V (probable disease-associated
FT                                mutation found in a patient with
FT                                infantile onset epileptic encephalopathy
FT                                with dyskinesia and microcephaly).
FT                                {ECO:0000269|PubMed:27864847}.
FT                                /FTId=VAR_078230.
FT   VARIANT     155    155       S -> F (in PNH1).
FT                                {ECO:0000269|PubMed:8306954}.
FT                                /FTId=VAR_005531.
FT   VARIANT     206    206       I -> F (in MCAHS2; dbSNP:rs201119959).
FT                                {ECO:0000269|PubMed:24706016}.
FT                                /FTId=VAR_071072.
FT   VARIANT     239    239       G -> R (in PNH1).
FT                                {ECO:0000269|PubMed:10087994}.
FT                                /FTId=VAR_015441.
FT   VARIANT     297    297       N -> D (in PNH1).
FT                                {ECO:0000269|PubMed:8167330}.
FT                                /FTId=VAR_005532.
FT   VARIANT     344    344       Missing (in MCAHS2).
FT                                {ECO:0000269|PubMed:24259288}.
FT                                /FTId=VAR_071073.
SQ   SEQUENCE   484 AA;  54127 MW;  34DCD074A3920852 CRC64;
     MACRGGAGNG HRASATLSRV SPGSLYTCRT RTHNICMVSD FFYPNMGGVE SHIYQLSQCL
     IERGHKVIIV THAYGNRKGI RYLTSGLKVY YLPLKVMYNQ STATTLFHSL PLLRYIFVRE
     RVTIIHSHSS FSAMAHDALF HAKTMGLQTV FTDHSLFGFA DVSSVLTNKL LTVSLCDTNH
     IICVSYTSKE NTVLRAALNP EIVSVIPNAV DPTDFTPDPF RRHDSITIVV VSRLVYRKGI
     DLLSGIIPEL CQKYPDLNFI IGGEGPKRII LEEVRERYQL HDRVRLLGAL EHKDVRNVLV
     QGHIFLNTSL TEAFCMAIVE AASCGLQVVS TRVGGIPEVL PENLIILCEP SVKSLCEGLE
     KAIFQLKSGT LPAPENIHNI VKTFYTWRNV AERTEKVYDR VSVEAVLPMD KRLDRLISHC
     GPVTGYIFAL LAVFNFLFLI FLRWMTPDSI IDVAIDATGP RGAWTNNYSH SKRGGENNEI
     SETR
//
